168 related articles for article (PubMed ID: 35339094)
1. The pathogenicity classification of PAH gene variants in the Iranian population.
Alibakhshi R; Kazeminia M; Moradi K
Comput Biol Chem; 2022 Jun; 98():107665. PubMed ID: 35339094
[TBL] [Abstract][Full Text] [Related]
2. Significance of utilizing in silico structural analysis and phenotypic data to characterize phenylalanine hydroxylase variants: A PAH landscape.
Himmelreich N; Ramón-Maiques S; Navarrete R; Castejon-Fernandez N; Garbade SF; Martinez A; Desviat LR; Pérez B; Blau N
Mol Genet Metab; 2024 Jun; 142(3):108514. PubMed ID: 38905920
[TBL] [Abstract][Full Text] [Related]
3. Specifications of the ACMG/AMP Variant Classification Guidelines for Germline
Hatton JN; Frone MN; Cox HC; Crowley SB; Hiraki S; Yokoyama NN; Abul-Husn NS; Amatruda JF; Anderson MJ; Bofill-De Ros X; Carr AG; Chao EC; Chen KS; Gu S; Higgs C; Machado J; Ritter D; Schultz KA; Soper ER; Wu MK; Mester JL; Kim J; Foulkes WD; Witkowski L; Stewart DR
Hum Mutat; 2023; 2023():. PubMed ID: 38084291
[TBL] [Abstract][Full Text] [Related]
4. Classification of BRCA2 Variants of Uncertain Significance (VUS) Using an ACMG/AMP Model Incorporating a Homology-Directed Repair (HDR) Functional Assay.
Hu C; Susswein LR; Roberts ME; Yang H; Marshall ML; Hiraki S; Berkofsky-Fessler W; Gupta S; Shen W; Dunn CA; Huang H; Na J; Domchek SM; Yadav S; Monteiro ANA; Polley EC; Hart SN; Hruska KS; Couch FJ
Clin Cancer Res; 2022 Sep; 28(17):3742-3751. PubMed ID: 35736817
[TBL] [Abstract][Full Text] [Related]
5. Unique aspects of sequence variant interpretation for inborn errors of metabolism (IEM): The ClinGen IEM Working Group and the Phenylalanine Hydroxylase Gene.
Zastrow DB; Baudet H; Shen W; Thomas A; Si Y; Weaver MA; Lager AM; Liu J; Mangels R; Dwight SS; Wright MW; Dobrowolski SF; Eilbeck K; Enns GM; Feigenbaum A; Lichter-Konecki U; Lyon E; Pasquali M; Watson M; Blau N; Steiner RD; Craigen WJ; Mao R;
Hum Mutat; 2018 Nov; 39(11):1569-1580. PubMed ID: 30311390
[TBL] [Abstract][Full Text] [Related]
6. Modeling the ACMG/AMP variant classification guidelines as a Bayesian classification framework.
Tavtigian SV; Greenblatt MS; Harrison SM; Nussbaum RL; Prabhu SA; Boucher KM; Biesecker LG;
Genet Med; 2018 Sep; 20(9):1054-1060. PubMed ID: 29300386
[TBL] [Abstract][Full Text] [Related]
7. Expanding ACMG variant classification guidelines into a general framework.
Masson E; Zou WB; Génin E; Cooper DN; Le Gac G; Fichou Y; Pu N; Rebours V; Férec C; Liao Z; Chen JM
Hum Genomics; 2022 Aug; 16(1):31. PubMed ID: 35974416
[TBL] [Abstract][Full Text] [Related]
8. Variant Classification Concordance using the ACMG-AMP Variant Interpretation Guidelines across Nine Genomic Implementation Research Studies.
Amendola LM; Muenzen K; Biesecker LG; Bowling KM; Cooper GM; Dorschner MO; Driscoll C; Foreman AKM; Golden-Grant K; Greally JM; Hindorff L; Kanavy D; Jobanputra V; Johnston JJ; Kenny EE; McNulty S; Murali P; Ou J; Powell BC; Rehm HL; Rolf B; Roman TS; Van Ziffle J; Guha S; Abhyankar A; Crosslin D; Venner E; Yuan B; Zouk H; ; Jarvik GP
Am J Hum Genet; 2020 Nov; 107(5):932-941. PubMed ID: 33108757
[TBL] [Abstract][Full Text] [Related]
9. Disease-specific ACMG/AMP guidelines improve sequence variant interpretation for hearing loss.
Patel MJ; DiStefano MT; Oza AM; Hughes MY; Wilcox EH; Hemphill SE; Cushman BJ; Grant AR; Siegert RK; Shen J; Chapin A; Boczek NJ; Schimmenti LA; Nara K; Kenna M; Azaiez H; Booth KT; Avraham KB; Kremer H; Griffith AJ; Rehm HL; Amr SS; Tayoun ANA;
Genet Med; 2021 Nov; 23(11):2208-2212. PubMed ID: 34230634
[TBL] [Abstract][Full Text] [Related]
10. Good performance of the criteria of American College of Medical Genetics and Genomics/Association for Molecular Pathology in prediction of pathogenicity of genetic variants causing thoracic aortic aneurysms and dissections.
Ponińska JK; Bilińska ZT; Truszkowska G; Michalak E; Podgórska A; Stępień-Wojno M; Chmielewski P; Lutyńska A; Płoski R
J Transl Med; 2022 Jan; 20(1):42. PubMed ID: 35078481
[TBL] [Abstract][Full Text] [Related]
11. Performance of ACMG-AMP Variant-Interpretation Guidelines among Nine Laboratories in the Clinical Sequencing Exploratory Research Consortium.
Amendola LM; Jarvik GP; Leo MC; McLaughlin HM; Akkari Y; Amaral MD; Berg JS; Biswas S; Bowling KM; Conlin LK; Cooper GM; Dorschner MO; Dulik MC; Ghazani AA; Ghosh R; Green RC; Hart R; Horton C; Johnston JJ; Lebo MS; Milosavljevic A; Ou J; Pak CM; Patel RY; Punj S; Richards CS; Salama J; Strande NT; Yang Y; Plon SE; Biesecker LG; Rehm HL
Am J Hum Genet; 2016 Jun; 98(6):1067-1076. PubMed ID: 27181684
[TBL] [Abstract][Full Text] [Related]
12. Spectrum of DDC variants causing aromatic l-amino acid decarboxylase (AADC) deficiency and pathogenicity interpretation using ACMG-AMP/ACGS recommendations.
Himmelreich N; Montioli R; Garbade SF; Kopesky J; Elsea SH; Carducci C; Voltattorni CB; Blau N
Mol Genet Metab; 2022 Dec; 137(4):359-381. PubMed ID: 36427457
[TBL] [Abstract][Full Text] [Related]
13. Application of ACMG criteria to classify variants in the human gene mutation database.
Qu HQ; Wang X; Tian L; Hakonarson H
J Hum Genet; 2019 Nov; 64(11):1091-1095. PubMed ID: 31451714
[TBL] [Abstract][Full Text] [Related]
14. Updated variant curation expert panel criteria and pathogenicity classifications for 251 variants for RYR1-related malignant hyperthermia susceptibility.
Johnston JJ; Dirksen RT; Girard T; Hopkins PM; Kraeva N; Ognoon M; Radenbaugh KB; Riazi S; Robinson RL; Saddic Iii LA; Sambuughin N; Saxena R; Shepherd S; Stowell K; Weber J; Yoo S; Rosenberg H; Biesecker LG
Hum Mol Genet; 2022 Nov; 31(23):4087-4093. PubMed ID: 35849058
[TBL] [Abstract][Full Text] [Related]
15. Specifications of the ACMG/AMP variant curation guidelines for the analysis of germline CDH1 sequence variants.
Lee K; Krempely K; Roberts ME; Anderson MJ; Carneiro F; Chao E; Dixon K; Figueiredo J; Ghosh R; Huntsman D; Kaurah P; Kesserwan C; Landrith T; Li S; Mensenkamp AR; Oliveira C; Pardo C; Pesaran T; Richardson M; Slavin TP; Spurdle AB; Trapp M; Witkowski L; Yi CS; Zhang L; Plon SE; Schrader KA; Karam R
Hum Mutat; 2018 Nov; 39(11):1553-1568. PubMed ID: 30311375
[TBL] [Abstract][Full Text] [Related]
16. A phenotype-enhanced variant classification framework to decrease the burden of missense variants of uncertain significance in type 1 long QT syndrome.
Bains S; Dotzler SM; Krijger C; Giudicessi JR; Ye D; Bikker H; Rohatgi RK; Tester DJ; Bos JM; Wilde AAM; Ackerman MJ
Heart Rhythm; 2022 Mar; 19(3):435-442. PubMed ID: 34798354
[TBL] [Abstract][Full Text] [Related]
17. Proposition of adjustments to the ACMG-AMP framework for the interpretation of MEN1 missense variants.
Romanet P; Odou MF; North MO; Saveanu A; Coppin L; Pasmant E; Mohamed A; Goudet P; Borson-Chazot F; Calender A; Béroud C; Lévy N; Giraud S; Barlier A
Hum Mutat; 2019 Jun; 40(6):661-674. PubMed ID: 30869828
[TBL] [Abstract][Full Text] [Related]
18. Refinement of the assignment to the ACMG/AMP BS3 and PS3 criteria of eight
Caleca L; Radice P
Front Oncol; 2023; 13():1146604. PubMed ID: 37168384
[TBL] [Abstract][Full Text] [Related]
19. Systematic Evaluation of
Kashiwa A; Aiba T; Makimoto H; Shimamoto K; Yamagata K; Kamakura T; Wada M; Miyamoto K; Inoue-Yamada Y; Ishibashi K; Noda T; Nagase S; Miyazaki A; Sakaguchi H; Shiraishi I; Yagihara N; Watanabe H; Aizawa Y; Makiyama T; Itoh H; Hayashi K; Yamagishi M; Sumitomo N; Yoshinaga M; Morita H; Ohe T; Miyamoto Y; Makita N; Yasuda S; Kusano K; Ohno S; Horie M; Shimizu W
Circ Genom Precis Med; 2020 Sep; ():. PubMed ID: 32936022
[No Abstract] [Full Text] [Related]
20. Fitting a naturally scaled point system to the ACMG/AMP variant classification guidelines.
Tavtigian SV; Harrison SM; Boucher KM; Biesecker LG
Hum Mutat; 2020 Oct; 41(10):1734-1737. PubMed ID: 32720330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
